Our portfolio

MVI is accelerating the development of malaria vaccines by testing multiple candidates simultaneously. We are strategically using our resources to support and advance a range of vaccine approaches that target both humoral and cellular immunity.

Portfolio Slide October 2014

Organizations listed above

GlaxoSmithKline (GSK)
Johns Hopkins University (JHU)
International Centre for Genetic Engineering and Biotechnology (ICGEB)
Malaria Vaccine Development Program (MVDP)
National Institute of Allergy and Infectious Diseases (NIAID)
Naval Medical Research Center (NMRC)
New York University (NYU)
Oxford University (Oxford U)
University of Pennsylvania (UPenn)
Walter and Eliza Hall Institute (WEHI)
Walter Reed Army Institute of Research (WRAIR)

Find out more about feasibility studies, translational projects, and vaccine candidates by clicking on the respective links. Find out more about the phases of clinical trials.

View the life cycle of the malaria parasite.